Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α.

Saved in:
Bibliographic Details
Title: Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α.
Authors: Echeverria I; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California at San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, School of Pharmacy, University of California at San Francisco, CA, USA.; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Liu Y; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gabelli SB; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Departments of Medicine and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Amzel LM; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Source: The FEBS journal [FEBS J] 2015 Sep; Vol. 282 (18), pp. 3528-42. Date of Electronic Publication: 2015 Jul 24.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1742-4658
DOI:10.1111/febs.13365